Supplementary Figures from MAP Kinase Pathway Alterations in <i>BRAF</i>-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
Nikhil Wagle(Dana-Farber Cancer Institute), Levi A. Garraway(Broad Institute), Ryan J. Sullivan(Dana-Farber Cancer Institute), Cory M. Johannessen(Novartis (China)), Keith T. Flaherty(Cancer Research Center), Scott L. Carter(Broad Institute), Daniel J. Treacy(Broad Institute), Kristin Anderka(Broad Institute), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Aaron McKenna(Dartmouth College), Dennie T. Frederick(Broad Institute), Donald P. Lawrence(Massachusetts General Hospital), Eran Hodis(Broad Institute), Mara Rosenberg(Broad Institute), Kristian Cibulskis(Broad Institute), Eva M. Goetz(Broad Institute), Gregory V. Kryukov(Broad Institute), Stacey Gabriel(Broad Institute), Danielle Perrin(Broad Institute), Deborah Farlow(Broad Institute), Zachary A. Cooper(AstraZeneca (Singapore)), Amaro Taylor‐Weiner(Critical Path Institute), Gad Getz(Broad Institute), Dennis C. Friedrich(Broad Institute), Sheila Fisher(Broad Institute)
Cited by 0
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k